{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:34:33Z","timestamp":1776990873469,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2022 Hebei Province Government-funded Excellent Talents Project in Clinical Medicine","award":["2100199-361003-19"],"award-info":[{"award-number":["2100199-361003-19"]}]},{"name":"2023 Hebei Province Medical-Science Research Project","award":["20230013"],"award-info":[{"award-number":["20230013"]}]},{"name":"2025 Hengrui-Hebei Innovation and Development Medical Cooperation Program","award":["HR202502105"],"award-info":[{"award-number":["HR202502105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43865-2","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:23:18Z","timestamp":1773386598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evodiamine alleviates MPTP-induced Parkinson\u2019s disease in mice by regulating gut microbiota and suppressing TLR4\/MyD88\/NF-kB pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunbo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"43865_CR1","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su, D. et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388, e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952 (2025).","journal-title":"BMJ"},{"key":"43865_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"key":"43865_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging. 24, 197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9 (2003).","journal-title":"Neurobiol. Aging"},{"key":"43865_CR4","doi-asserted-by":"publisher","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018 (2019).","DOI":"10.1152\/physrev.00018.2018"},{"key":"43865_CR5","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","volume":"84","author":"JC Claudino Dos Santos","year":"2023","unstructured":"Claudino Dos Santos, J. C., Lima, M. P. P., Brito, G. A. C. & Viana, G. S. B. Role of enteric glia and microbiota-gut-brain axis in Parkinson disease pathogenesis. Ageing Res. Rev. 84, 101812. https:\/\/doi.org\/10.1016\/j.arr.2022.101812 (2023).","journal-title":"Ageing Res. Rev."},{"key":"43865_CR6","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.arr.2022.101759","volume":"82","author":"M Bi","year":"2022","unstructured":"Bi, M. et al. Emerging insights between gut microbiome dysbiosis and Parkinson\u2019s disease: Pathogenic and clinical relevance. Ageing Res. Rev. 82, 101759. https:\/\/doi.org\/10.1016\/j.arr.2022.101759 (2022).","journal-title":"Ageing Res. Rev."},{"key":"43865_CR7","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1007\/s00253-023-12789-6","volume":"107","author":"S Nie","year":"2023","unstructured":"Nie, S. & Ge, Y. The link between the gut microbiome, inflammation, and Parkinson\u2019s disease. Appl. Microbiol. Biotechnol. 107, 6737\u20136749. https:\/\/doi.org\/10.1007\/s00253-023-12789-6 (2023).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"43865_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang, X., Tang, B. & Guo, J. Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener. 12, 59. https:\/\/doi.org\/10.1186\/s40035-023-00392-8 (2023).","journal-title":"Transl Neurodegener"},{"key":"43865_CR9","doi-asserted-by":"publisher","first-page":"113164","DOI":"10.1016\/j.jep.2020.113164","volume":"262","author":"Q Sun","year":"2020","unstructured":"Sun, Q., Xie, L., Song, J., Li, X. & Evodiamine A review of its pharmacology, toxicity, pharmacokinetics and preparation researches. J. Ethnopharmacol. 262, 113164. https:\/\/doi.org\/10.1016\/j.jep.2020.113164 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"43865_CR10","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s11064-014-1356-5","volume":"39","author":"T Zhao","year":"2014","unstructured":"Zhao, T. et al. Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3\u03b2, down-regulated NF-\u03baB expression, and ameliorated BBB permeability. Neurochem Res. 39, 1612\u20131620. https:\/\/doi.org\/10.1007\/s11064-014-1356-5 (2014).","journal-title":"Neurochem Res."},{"key":"43865_CR11","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.3390\/ijms22105347","volume":"22","author":"CH Chou","year":"2021","unstructured":"Chou, C. H. & Yang, C. R. Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity. Int. J. Mol. Sci. 22, 5347. https:\/\/doi.org\/10.3390\/ijms22105347 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"43865_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopha.2018.12.033","volume":"110","author":"P Shen","year":"2019","unstructured":"Shen, P. et al. Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-\u03baB and NLRP3 inflammasome. Biomed. Pharmacother. 110, 786\u2013795. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.033 (2019).","journal-title":"Biomed. Pharmacother"},{"key":"43865_CR13","doi-asserted-by":"publisher","first-page":"104978","DOI":"10.1016\/j.phrs.2020.104978","volume":"159","author":"MX Wang","year":"2020","unstructured":"Wang, M. X. et al. Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production. Pharmacol. Res. 159, 104978. https:\/\/doi.org\/10.1016\/j.phrs.2020.104978 (2020).","journal-title":"Pharmacol. Res."},{"key":"43865_CR14","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"TI Kam","year":"2020","unstructured":"Kam, T. I., Hinkle, J. T., Dawson, T. M. & Dawson, V. L. Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol. Dis. 144, 105028. https:\/\/doi.org\/10.1016\/j.nbd.2020.105028 (2020).","journal-title":"Neurobiol. Dis."},{"key":"43865_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai, B. S., Monahan, A. J., Carvey, P. M. & Hendey, B. Blood-brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: implications for drug therapy. Cell. Transpl. 16, 285\u2013299. https:\/\/doi.org\/10.3727\/000000007783464731 (2007).","journal-title":"Cell. Transpl."},{"key":"43865_CR16","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica, R. et al. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 73, 1752\u20131758. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34af5 (2009).","journal-title":"Neurology"},{"key":"43865_CR17","doi-asserted-by":"publisher","unstructured":"Diaz Heijtz, R. et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U. S. A. 108, 3047\u20133052. https:\/\/doi.org\/10.1073\/pnas.1010529108 (2011).","DOI":"10.1073\/pnas.1010529108"},{"key":"43865_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2982.2010.01620.x","volume":"23","author":"KM Neufeld","year":"2011","unstructured":"Neufeld, K. M., Kang, N., Bienenstock, J. & Foster, J. A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 23, 255\u2013264. https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01620.x (2011).","journal-title":"Neurogastroenterol Motil."},{"key":"43865_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","volume":"141","author":"P Bercik","year":"2011","unstructured":"Bercik, P. et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599\u2013609. https:\/\/doi.org\/10.1053\/j.gastro.2011.04.052 (2011). 609.e1-3.","journal-title":"Gastroenterology"},{"key":"43865_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jep.2020.113164","volume":"21","author":"LY Hung","year":"2024","unstructured":"Hung, L. Y. & Margolis, K. G. Autism spectrum disorders and the gastrointestinal tract: insights into mechanisms and clinical relevance. Nat. Rev. Gastroenterol. Hep. 21, 142\u2013163. https:\/\/doi.org\/10.1016\/j.jep.2020.113164 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hep"},{"key":"43865_CR21","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/19490976.2020.1747329","volume":"11","author":"Z Dan","year":"2020","unstructured":"Dan, Z. et al. Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder. Gut Microbes. 11, 1246\u20131267. https:\/\/doi.org\/10.1080\/19490976.2020.1747329 (2020).","journal-title":"Gut Microbes"},{"key":"43865_CR22","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.3390\/ijms25126701","volume":"12","author":"A De Sales-Mill\u00e1n","year":"2024","unstructured":"De Sales-Mill\u00e1n, A. et al. Comprehensive Analysis of Gut Microbiota Composition and Functional Metabolism in Children with Autism Spectrum Disorder and Neurotypical Children: Implications for Sex-Based Differences and Metabolic Dysregulation. Int. J. Mol. Sci. 12, 6701. https:\/\/doi.org\/10.3390\/ijms25126701 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"43865_CR23","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","volume":"9","author":"DW Kang","year":"2019","unstructured":"Kang, D. W. et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci. Rep. 9, 5821. https:\/\/doi.org\/10.1038\/s41598-019-42183-0 (2019).","journal-title":"Sci. Rep."},{"key":"43865_CR24","doi-asserted-by":"publisher","unstructured":"Ghimire, S. et al. Specific microbial ratio in the gut microbiome is associated with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 122, e2413953122. https:\/\/doi.org\/10.1073\/pnas.2413953122 (2025).","DOI":"10.1073\/pnas.2413953122"},{"key":"43865_CR25","doi-asserted-by":"publisher","first-page":"102055","DOI":"10.1016\/j.xcrm.2025.102055","volume":"6","author":"LA Schwerdtfeger","year":"2025","unstructured":"Schwerdtfeger, L. A. et al. Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell. Rep. Med. 6, 102055. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102055 (2025).","journal-title":"Cell. Rep. Med."},{"key":"43865_CR26","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell 167, 1468\u20131480e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018 (2016).","journal-title":"Cell"},{"key":"43865_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-024-00766-0","volume":"19","author":"MF Munoz-Pinto","year":"2024","unstructured":"Munoz-Pinto, M. F. et al. Gut-first Parkinson\u2019s disease is encoded by gut dysbiome. Mol. Neurodegener. 19, 78. https:\/\/doi.org\/10.1186\/s13024-024-00766-0 (2024).","journal-title":"Mol. Neurodegener"},{"key":"43865_CR28","doi-asserted-by":"publisher","first-page":"2284247","DOI":"10.1080\/19490976.2023.2284247","volume":"15","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y. et al. Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design. Gut Microbes. 15, 2284247. https:\/\/doi.org\/10.1080\/19490976.2023.2284247 (2023).","journal-title":"Gut Microbes"},{"key":"43865_CR29","doi-asserted-by":"publisher","first-page":"102563","DOI":"10.1016\/j.eclinm.2024.102563","volume":"71","author":"A Bruggeman","year":"2024","unstructured":"Bruggeman, A. et al. Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial. EClinicalMedicine 71, 102563. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102563 (2024).","journal-title":"EClinicalMedicine"},{"key":"43865_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-025-01509-x","author":"F Han","year":"2025","unstructured":"Han, F. et al. Potential Transmission of Alpha-Synuclein from the Gastrointestinal Tract to the Substantia Nigra along the Vagal Afferent Pathway. Neurosci. Bull. https:\/\/doi.org\/10.1007\/s12264-025-01509-x (2025).","journal-title":"Neurosci. Bull."},{"key":"43865_CR31","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"21","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology 21, 1996\u20132002. https:\/\/doi.org\/10.1212\/WNL.0000000000003961 (2017).","journal-title":"Neurology"},{"key":"43865_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease. Neuron 103, 627\u2013641. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035 (2019). .e7.","journal-title":"Neuron"},{"key":"43865_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo, P. et al. Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut 68, 829\u2013843. https:\/\/doi.org\/10.1136\/gutjnl-2018-316844 (2019).","journal-title":"Gut"},{"key":"43865_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","volume":"51","author":"F Zhu","year":"2019","unstructured":"Zhu, F. et al. The risk of Parkinson\u2019s disease in inflammatory bowel disease: A systematic review and meta-analysis. Dig. Liver Dis. 51, 38\u201342. https:\/\/doi.org\/10.1016\/j.dld.2018.09.017 (2019).","journal-title":"Dig. Liver Dis."},{"key":"43865_CR35","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/jcm8081191","volume":"8","author":"S Park","year":"2018","unstructured":"Park, S. et al. Patients with Inflammatory Bowel Disease are at an increased risk of Parkinson\u2019s Disease: A South Korean Nationwide Population-Based Study. J. Clin. Med. 8, 1191. https:\/\/doi.org\/10.3390\/jcm8081191 (2018).","journal-title":"J. Clin. Med."},{"key":"43865_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinson Dis. 7, 27. https:\/\/doi.org\/10.1038\/s41531-021-00156-z (2021).","journal-title":"NPJ Parkinson Dis."},{"key":"43865_CR37","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-kB pathway through microbiota-gut-brain axis. Acta Pharm. Sin B. 11, 2859\u20132879. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.020 (2021).","journal-title":"Acta Pharm. Sin B"},{"key":"43865_CR38","doi-asserted-by":"publisher","unstructured":"Zhou, X. et al. Neuroprotective effect of ceftriaxone on MPTP-induced Parkinson\u2019s disease mouse model by regulating inflammation and intestinal microbiota. Oxid. Med. Cell. Longev. 2021 (9424582). https:\/\/doi.org\/10.1155\/2021\/9424582 (2021).","DOI":"10.1155\/2021\/9424582"},{"key":"43865_CR39","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00415-019-09321-0","volume":"267","author":"M Rolli-Derkinderen","year":"2020","unstructured":"Rolli-Derkinderen, M. et al. Is Parkinson\u2019s disease a chronic low-grade inflammatory bowel disease? J. Neurol. 267, 2207\u20132213. https:\/\/doi.org\/10.1007\/s00415-019-09321-0 (2020).","journal-title":"J. Neurol."},{"key":"43865_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"43865_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser, M. C. & Tansey, M. G. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Parkinson Dis. 3, 3. https:\/\/doi.org\/10.1038\/s41531-016-0002-0 (2017).","journal-title":"NPJ Parkinson Dis."},{"key":"43865_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","volume":"112","author":"ND Nuzum","year":"2020","unstructured":"Nuzum, N. D. et al. Gut microbiota differences between healthy older adults and individuals with Parkinson\u2019s disease: A systematic review. Neurosci. Biobehav Rev. 112, 227\u2013241. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.02.003 (2020).","journal-title":"Neurosci. Biobehav Rev."},{"key":"43865_CR43","doi-asserted-by":"publisher","first-page":"e00797","DOI":"10.1128\/mSystems.00797-20","volume":"5","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki, H. et al. Short-chain fatty acid-producing gut microbiota is decreased in Parkinson\u2019s disease but not in rapid-eye-movement sleep behavior disorder. mSystems 5, e00797\u2013e00720. https:\/\/doi.org\/10.1128\/mSystems.00797-20 (2020).","journal-title":"mSystems"},{"key":"43865_CR44","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea, M. S. et al. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov. Disord. 35, 1208\u20131217. https:\/\/doi.org\/10.1002\/mds.28052 (2020).","journal-title":"Mov. Disord"},{"key":"43865_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho, V. T. E. et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol. Neurodegener. 16, 6. https:\/\/doi.org\/10.1186\/s13024-021-00427-6 (2021).","journal-title":"Mol. Neurodegener"},{"key":"43865_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov, V. A. et al. Analysis of Gut Microbiota in Patients with Parkinson\u2019s Disease. Bull. Exp. Biol. Med. 162, 734\u2013737. https:\/\/doi.org\/10.1007\/s10517-017-3700-7 (2017).","journal-title":"Bull. Exp. Biol. Med."},{"key":"43865_CR47","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options. Brain 144, 2571\u20132593. https:\/\/doi.org\/10.1093\/brain\/awab156 (2021).","journal-title":"Brain"},{"key":"43865_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","volume":"27","author":"HM Hamer","year":"2008","unstructured":"Hamer, H. M. et al. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104\u2013119. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03562.x (2008).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"43865_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat. Disord. 32, 66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019 (2016).","journal-title":"Parkinsonism Relat. Disord"},{"key":"43865_CR50","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, e848\u2013e858. https:\/\/doi.org\/10.1212\/WNL.0000000000013225 (2022).","journal-title":"Neurology"},{"key":"43865_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0076-6879(95)53026-6","volume":"253","author":"PS Cohen","year":"1995","unstructured":"Cohen, P. S. & Laux, D. C. Bacterial adhesion to and penetration of intestinal mucus in vitro. Methods Enzymol. 253, 309\u2013314. https:\/\/doi.org\/10.1016\/s0076-6879(95)53026-6 (1995).","journal-title":"Methods Enzymol."},{"key":"43865_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00005176-199510000-00004","volume":"21","author":"CJ Smith","year":"1995","unstructured":"Smith, C. J., Kaper, J. B. & Mack, D. R. Intestinal mucin inhibits adhesion of human enteropathogenic Escherichia coli to HEp-2 cells. J. Pediatr. Gastroenterol. Nutr. 21, 269\u2013276. https:\/\/doi.org\/10.1097\/00005176-199510000-00004 (1995).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"43865_CR53","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339\u20131353. https:\/\/doi.org\/10.1016\/j.cell.2016.10.043 (2016).","journal-title":"Cell"},{"key":"43865_CR54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.celrep.2017.03.080","volume":"19","author":"SS Seregin","year":"2017","unstructured":"Seregin, S. S. et al. NLRP6 protects Il10-\/- mice from colitis by limiting colonization of Akkermansia muciniphila. Cell. Rep. 19, 733\u2013745. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.080 (2017).","journal-title":"Cell. Rep."},{"key":"43865_CR55","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen, Z. D. et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 13, 6958. https:\/\/doi.org\/10.1038\/s41467-022-34667-x (2022).","journal-title":"Nat. Commun."},{"key":"43865_CR56","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat. Commun. 10, 310. https:\/\/doi.org\/10.1038\/s41467-019-08294-y (2019).","journal-title":"Nat. Commun."},{"key":"43865_CR57","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J. & Balskus, E. P. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 364, eaau6323. https:\/\/doi.org\/10.1126\/science.aau6323 (2019).","journal-title":"Science"},{"key":"43865_CR58","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 461. https:\/\/doi.org\/10.3389\/fimmu.2014.00461 (2014).","journal-title":"Front. Immunol."},{"key":"43865_CR59","doi-asserted-by":"publisher","unstructured":"Biesmans, S. et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediat Inflamm. 2013 (271359). https:\/\/doi.org\/10.1155\/2013\/271359 (2013).","DOI":"10.1155\/2013\/271359"},{"key":"43865_CR60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487. https:\/\/doi.org\/10.1038\/nature21029 (2017).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43865-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43865-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43865-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:37:26Z","timestamp":1776987446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43865-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43865"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43865-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Animal Ethics Committee of Hebei General Hospital (Approval Number 202225).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"13353"}}